𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pseudoprogression after high-dose busulfan-thiotepa with autologous stem cell transplantation and radiation therapy in children with brain tumors: Impact on survival

✍ Scribed by Negretti, L.; Blanchard, P.; Couanet, D.; Kieffer, V.; Goma, G.; Habrand, J. L.; Dhermain, F.; Valteau-Couanet, D.; Grill, J.; Dufour, C.


Book ID
125501290
Publisher
Duke University Press
Year
2012
Tongue
English
Weight
195 KB
Volume
14
Category
Article
ISSN
1522-8517

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Phase I study of high-dose thiotepa with
✍ Pession, Andrea; Prete, Arcangelo; Locatelli, Franco; Bella, Santiago; Melchiond πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 2 views

Background. The aim of this phase I study was to define the maximum tolerated dose (MTD) of thiotepa (TT), administered with busulfan (BU) 480 mg/m 2 and etoposide 2,400 mg/m 2 , followed by autologous bone marrow transplantation (ABMT) or peripheral blood stem cell transplantation (APBSCT) support